Login

Aviva and Socius lodge plans for £1 billion London Cancer Hub

Plans are for the Institute of Cancer Research's Sutton site
The proposed London Cancer Hub. (Aviva and Socius)
The proposed London Cancer Hub. (Aviva and Socius)

Aviva Capital Partners, Aviva’s in-house capital unit that invests in infrastructure and real estate projects, and mixed-use developer Socius have lodged plans for an £1 billion development they say will be the world’s leading centre for cancer research and treatment.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE